Donald Trump’s election win is clouding the outlook for mortgage rates even before he gets back to the White House.

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

If you have watched a semi-decent courtroom drama, you know that the Constitution guarantees legal counsel for criminal proceedings to be appointed if the accused does not have the means ...

Insider threats In an insider threat, people who already have access to some systems, such as employees, contractors, or customers, cause a security breach or financial loss. In some cases, this harm ...

In a strategic move to address the unprecedented demand for AI transformation, Accenture and Avanade, their joint venture with Microsoft Corporation , are launching a copilot business transformation ...